These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24091326)

  • 1. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.
    Cheng JC; Bai A; Beckham TH; Marrison ST; Yount CL; Young K; Lu P; Bartlett AM; Wu BX; Keane BJ; Armeson KE; Marshall DT; Keane TE; Smith MT; Jones EE; Drake RR; Bielawska A; Norris JS; Liu X
    J Clin Invest; 2013 Oct; 123(10):4344-58. PubMed ID: 24091326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
    Mahdy AE; Cheng JC; Li J; Elojeimy S; Meacham WD; Turner LS; Bai A; Gault CR; McPherson AS; Garcia N; Beckham TH; Saad A; Bielawska A; Bielawski J; Hannun YA; Keane TE; Taha MI; Hammouda HM; Norris JS; Liu X
    Mol Ther; 2009 Mar; 17(3):430-8. PubMed ID: 19107118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.
    Hadas Y; Vincek AS; Youssef E; Żak MM; Chepurko E; Sultana N; Sharkar MTK; Guo N; Komargodski R; Kurian AA; Kaur K; Magadum A; Fargnoli A; Katz MG; Hossain N; Kenigsberg E; Dubois NC; Schadt E; Hajjar R; Eliyahu E; Zangi L
    Circulation; 2020 Mar; 141(11):916-930. PubMed ID: 31992066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
    Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
    Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy.
    Liu X; Cheng JC; Turner LS; Elojeimy S; Beckham TH; Bielawska A; Keane TE; Hannun YA; Norris JS
    Expert Opin Ther Targets; 2009 Dec; 13(12):1449-58. PubMed ID: 19874262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
    Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
    J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells.
    Morad SA; Messner MC; Levin JC; Abdelmageed N; Park H; Merrill AH; Cabot MC
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):635-45. PubMed ID: 23263160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid ceramidase as a therapeutic target in metastatic prostate cancer.
    Camacho L; Meca-Cortés O; Abad JL; García S; Rubio N; Díaz A; Celià-Terrassa T; Cingolani F; Bermudo R; Fernández PL; Blanco J; Delgado A; Casas J; Fabriàs G; Thomson TM
    J Lipid Res; 2013 May; 54(5):1207-20. PubMed ID: 23423838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
    Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
    J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide.
    Turner LS; Cheng JC; Beckham TH; Keane TE; Norris JS; Liu X
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):30-7. PubMed ID: 21116286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells.
    Zhang Y; Xu Z; Ding J; Tan C; Hu W; Li Y; Huang W; Xu Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):174. PubMed ID: 30053873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy.
    Saad AF; Meacham WD; Bai A; Anelli V; Elojeimy S; Mahdy AE; Turner LS; Cheng J; Bielawska A; Bielawski J; Keane TE; Obeid LM; Hannun YA; Norris JS; Liu X
    Cancer Biol Ther; 2007 Sep; 6(9):1455-60. PubMed ID: 17881906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling.
    Beckham TH; Cheng JC; Lu P; Marrison ST; Norris JS; Liu X
    PLoS One; 2013; 8(10):e76593. PubMed ID: 24098536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B.
    Beckham TH; Lu P; Cheng JC; Zhao D; Turner LS; Zhang X; Hoffman S; Armeson KE; Liu A; Marrison T; Hannun YA; Liu X
    Int J Cancer; 2012 Nov; 131(9):2034-43. PubMed ID: 22322590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
    Mendonca MS; Turchan WT; Alpuche ME; Watson CN; Estabrook NC; Chin-Sinex H; Shapiro JB; Imasuen-Williams IE; Rangel G; Gilley DP; Huda N; Crooks PA; Shapiro RH
    Free Radic Biol Med; 2017 Nov; 112():318-326. PubMed ID: 28782644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.
    Valerie NC; Casarez EV; Dasilva JO; Dunlap-Brown ME; Parsons SJ; Amorino GP; Dziegielewski J
    Cancer Res; 2011 Nov; 71(21):6817-26. PubMed ID: 21903767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
    Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
    Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.